Matter Bio submits first IND application for Lm-LLO-TT

Myosin Therapeutics doses first patient in Phase 1/2 study of MT-125 in GBM

Nanjing Leads Biolabs receives Chinese approval for pivotal Phase III trial of PD-L1/4-1BB bispecific antibody

Accro Bioscience completes USD50m Series C financing

AstraZeneca wins US approval for Baxfendy as first aldosterone synthase inhibitor for hypertension

GSK's Arexvy gains expanded approval in Japan for at-risk adults aged 18-49

SciBase research highlights Nevisense potential in age-related skin analysis

Atisama Therapeutics reports progress in Phase 1 study of RB042

Racura Oncology reports positive Safety Review Committee recommendation in ongoing CPACS trial of RC220

Akeso reports results from Phase II trial of ligufalimab combination therapy in AML

Keenova Therapeutics reports final data from ventral curvature analysis of XIAFLEX in Peyronie's disease

Tenaya Therapeutics reports interim RIDGE-1 data showing reduced arrhythmia burden with TN-401

SN BioScience reports first patient dosed in global Phase 1b/2 clinical trial of SNB-101

Intensity Therapeutics receives Cancer Treatment Technology Innovator of the Year award

AstraZeneca reports survival gains in Phase III bladder cancer trial